Brief: Senzime: New Study Confirms Effectiveness Of Tetragraph
Sept 7 (Reuters) - Senzime AB (publ) SEZI.ST :
* NEW US STUDY CONFIRMS THE EFFECTIVENESS OF TETRAGRAPH QUANTITATIVE NEUROMUSCULAR BLOCKADE
MONITOR FOR CHILDREN
* STUDY CONCLUDES THAT TETRAGRAPH, COMPANY'S ELECTROMYOGRAPHY (EMG)-BASED MONITOR, IS
EFFECTIVE
FOR MONITORING NEUROMUSCULAR BLOCKADE IN CHILDREN
Source text for Eikon: ID:nMFNzv9L5
Further company coverage: SEZI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Senzime AB (publ)
See all newsBrief: Senzime Q3 Sales Up At SEK 30.1 Million
Sweden's Senzime Q3 sales rise on strong sensor demand
Brief: Senzime Reaffirms Target Of Positive Cash Flow In Q4 2026
Brief: Senzime Announces New Non-Dilutive Credit Facility Of SEK 35 Mln
Brief: Senzime Wins Additional Major US Hospital Network Contract